Cover Image

PAMAM-calix-dendrimers as carriers for 5-fluorouracil: complexation, aggregation, and in vitro antitumor activity

Pavel Padnya, Ilona Svintsova, Igor Shiabiev, Dmitry Pysin, Olga Mostovaya, Bahdan Ranishenka, Alesia Stanavaya, Viktar Abashkin, Dzmitry Shcharbin, Anastasia Nazarova, Ivan Stoikov

Abstract


Despite a number of serious challenges and limitations in clinical use, drug therapy is considered one of the most common approaches to treating cancer. However, many types of cancer become resistant to antitumor drugs. Modern supramolecular chemistry provides a variety of compounds and materials that can be used to develop targeted drug delivery approaches, thereby enhancing therapeutic efficacy. Dendrimers are one example of such materials. This study presents an approach to creating supramolecular systems based on poly(amidoamine) dendrimers with a thiacalix[4]arene core (PAMAM-calix-dendrimers), capable of binding and delivering 5-fluorouracil (5-Fu). Fluorescence spectroscopy has demonstrated the good binding of 5-Fu by G1–G3 PAMAM-calix-dendrimers (logKa = 3.15–3.62) regardless of the macrocyclic core conformation. Self-assembly of the PAMAM-calix-dendrimers/5-Fu supramolecular systems was studied by dynamic light scattering and transmission electron microscopy. Loading and release of 5-Fu were evaluated by UV-Vis spectroscopy. The encapsulation efficiency and loading capacity increased slightly in the following order: G3-cone < G3-paco < G3-alt. For all dendrimers studied, 95% release of 5-Fu was observed within 4 h. An in vitro HeLa tumor cell model showed a positive trend (up to 20%) toward overcoming resistance to 5-Fu chemotherapy when G3-alt is used. These results provide proof of concept for using macrocyclic dendrimers to create anticancer drug delivery systems.

Keywords


dendrimers; 5-fluorouracil; self-assembly; drug delivery systems; antitumor activity

Full Text:

PDF

References


Cancer. Available online: https://www.who.int/health-topics/cancer. Accessed on 27 November 2025).

Alqosaibi AI. Nanocarriers for anticancer drugs: Challenges and perspectives. Saudi J Biol Sci. 2022;29(6):103298. doi:10.1016/j.sjbs.2022.103298

Sharma P, Dahiya M, Raina N, Joon P, Dhakla P, Yadav M. Challenges and future directions of anticancer molecules and their delivery. Handb Oncobiology From Basic to Clin Sci. 2024:1075–83. doi:10.1007/978-981-99-6263-1_53

Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3(1):7. doi:10.1038/s41392-017-0004-3

Ji Y, Guo Y, Zhang G, Sanyal A, Shen M, Shi X. Combination of dendrimers and exosomes: implications for biomedical applications. Macromol Biosci. 2025;25(6):2500014. doi:10.1002/mabi.202500014

Van der meel R, Sulheim E, Shi Y, Kiessling F, Mulder WJ, Lammers T. Smart cancer nanomedicine. Nat Nanotechnol. 2019;14(11):1007–17. doi:10.1038/s41565-019-0567-y

Li X, Hu Y, Zhang X, Shi X, Parak WJ, Pich A. Transvascular transport of nanocarriers for tumor delivery. Nat Commun. 2024;15(1):8172. doi:10.1038/s41467-024-52416-0

Zhang C, Guo Y, Shen M, Shi X. Dendrimer‐Based Nanodrugs for Chemodynamic Therapy of Tumors. Adv Nanobiomed Res. 2024;4(4):2300149. doi:10.1002/anbr.202300149

Palmerston mendes L, Pan J, Torchilin V. Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy. Molecules. 2017;22(9):1401. doi:10.3390/molecules22091401

Patel V, Patel P, Patel JV, Patel PM. Dendrimer as a versatile platform for biomedical application: A review. J Indian Chem Soc. 2022;99(7):100516. doi:10.1016/j.jics.2022.100516

Mekuria SL, Li J, Song C, Gao Y, Ouyang Z, Shen M, Shi X. Facile formation of PAMAM dendrimer nanoclusters for enhanced gene delivery and cancer gene therapy. ACS Appl Bio Mater. 2021;4(9):7168–75. doi:10.1021/acsabm.1c00743

Kisakova LA, Apartsin EK, Nizolenko LF, Karpenko LI. Dendrimer-mediated delivery of DNA and RNA vaccines. Pharmaceutics. 2023;15(4):1106. doi:10.3390/pharmaceutics15041106

Alamos-Musre S, Beltrán-Chacana D, Moyano J, Márquez-Miranda V, Duarte Y, Miranda-Rojas S, Olguín Y, Fuentes JA, González-Nilo D, Otero MC. From structure to function: the promise of pamam dendrimers in biomedical applications. Pharmaceutics. 2025;17(7):927. doi:10.3390/pharmaceutics17070927

Kheraldine H, Rachid O, Habib AM, Al moustafa A, Benter IF, Akhtar S. Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential. Adv Drug Deliv Rev. 2021;178:113908. doi:10.1016/j.addr.2021.113908

Akhtar MJ, Ahamed M, Alhadlaq HA, Alrokayan SA, Kumar S. Targeted anticancer therapy: Overexpressed receptors and nanotechnology. Clin Chim Acta. 2014;436:78–92. doi:10.1016/j.cca.2014.05.004

Tarach P, Janaszewska A. Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy. Int J Mol Sci. 2021;22(6):2912. doi:10.3390/ijms22062912

Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–8. doi:10.1038/nrc1074

Ewert de oliveira B, Junqueira amorim OH, Lima LL, Rezende RA, Mestnik NC, Bagatin E, Leonardi GR. 5-Fluorouracil, innovative drug delivery systems to enhance bioavailability for topical use. J Drug Deliv Sci Technol. 2021;61:102155. doi:10.1016/j.jddst.2020.102155

Valencia-Lazcano AA, Hassan D, Pourmadadi M, Shamsabadipour A, Behzadmehr R, Rahdar A, Medina DI, Díez-Pascual AM. 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy. Eur J Med Chem. 2023;246:114995. doi:10.1016/j.ejmech.2022.114995

Szota M, Reczyńska-Kolman K, Pamuła E, Michel O, Kulbacka J, Jachimska B. Poly(amidoamine) dendrimers as nanocarriers for 5-fluorouracil: effectiveness of complex formation and cytotoxicity studies. Int J Mol Sci. 2021;22(20):11167. doi:10.3390/ijms222011167

Szota M, Wolski P, Carucci C, Marincola FC, Gurgul J, Panczyk T, Salis A, Jachimska B. Effect of ionization degree of poly(amidoamine) dendrimer and 5-fluorouracil on the efficiency of complex formation—a theoretical and experimental approach. Int J Mol Sci. 2023;24(1):819. doi:10.3390/ijms24010819

Bulkurcuoğlu B, Gürbüz MU, Tyciakova S, Pavlov K, Mojzesova N, Matuskova M, Tülü M, Erçelen Ş. Multifunctional PAMAM dendrimers carrying SAHA, 5‐FU, and a therapeutic gene for targeted co‐delivery toward colorectal cancer cells. Biotechnol J. 2024;19(11):e202400362. doi:10.1002/biot.202400362

Chen S, Ouyang H, He D, Liu D, Wang X, Chen H, Pan W, Li Q, Xie W, Yu C. Functionalized PAMAM-based nanoformulation for targeted delivery of 5-fluorouracil in hepatocellular carcinoma. Curr Pharm Des. 2022;28(25):2113–25. doi:10.2174/1381612828666220506111918

Buczkowski A, Sekowski S, Grala A, Palecz D, Milowska K, Urbaniak P, Gabryelak T, Piekarski H, Palecz B. Interaction between PAMAM-NH2 G4 dendrimer and 5-fluorouracil in aqueous solution. Int J Pharm. 2011;408(1-2):266–70. doi:10.1016/j.ijpharm.2011.02.014

Jin Y, Ren X, Wang W, Ke L, Ning E, Du L, Bradshaw J. A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting. Int J Pharm. 2011;420(2):378–84. doi:10.1016/j.ijpharm.2011.08.053

Janaszewska A, Lazniewska J, Trzepiński P, Marcinkowska M, Klajnert-Maculewicz B. Cytotoxicity of Dendrimers. Biomolecules. 2019;9(8):330. doi:10.3390/biom9080330

Mostovaya O, Padnya P, Shiabiev I, Mukhametzyanov T, Stoikov I. PAMAM-calix-dendrimers: Synthesis and Thiacalixarene Conformation Effect on DNA Binding. Int J Mol Sci. 2021;22(21):11901. doi:10.3390/ijms222111901

Mostovaya O, Shiabiev I, Pysin D, Stanavaya A, Abashkin V, Shcharbin D, Padnya P, Stoikov I. PAMAM-Calix-Dendrimers: Second Generation Synthesis, Fluorescent Properties and Catecholamines Binding. Pharmaceut. 2022;14(12):2748. doi:10.3390/pharmaceutics14122748

Mostovaya O, Shiabiev I, Ovchinnikov D, Pysin D, Mukhametzyanov T, Stanavaya A, Abashkin V, Shcharbin D, Khannanov A, Kutyreva M, Shen M, Shi X, Padnya P, Stoikov I. PAMAM-calix-dendrimers: third generation synthesis and impact of generation and macrocyclic core conformation on hemotoxicity and calf thymus dna Binding. Pharmaceutics. 2024;16(11):1379. doi:10.3390/pharmaceutics16111379

Padnya P, Shiabiev I, Pysin D, Gerasimova T, Ranishenka B, Stanavaya A, Abashkin V, Shcharbin D, Shi X, Shen M, Nazarova A, Stoikov I. Non-viral systems based on PAMAM-calix-dendrimers for regulatory siRNA delivery into cancer cells. Int J Mol Sci. 2024;25(23):12614. doi:10.3390/ijms252312614

Padnya P, Mostovaya O, Ovchinnikov D, Shiabiev I, Pysin D, Akhmedov A, Mukhametzyanov T, Lyubina A, Voloshina A, Petrov K, Stoikov I. Combined antimicrobial agents based on self-assembled PAMAM-calix-dendrimers/lysozyme nanoparticles: Design, antibacterial properties and cytotoxicity. J Mol Liq. 2023;389:122838. doi:10.1016/j.molliq.2023.122838

Shiabiev I, Pysin D, Kharlamova A, Zueva I, Petrov K, Bukharov M, Babaeva O, Mostovaya O, Padnya P, Stoikov I. Design of reversible cholinesterase inhibitors: Fine-tuning of enzymatic activity by PAMAM-calix-dendrimers. Int J Biol Macromol. 2025;287:138503. doi:10.1016/j.ijbiomac.2024.138503

Nazarova A, Shiabiev I, Shibaeva K, Mostovaya O, Mukhametzyanov T, Khannanov A, Evtugyn V, Zelenikhin P, Shi X, Shen M, Padnya P, Stoikov I. Thiacalixarene carboxylic acid derivatives as inhibitors of lysozyme fibrillation. Int J Mol Sci. 2024;25(9):4721. doi:10.3390/ijms25094721

Mostovaya O, Vavilova A, Gazizova A, Stoikov I. Cyclophane-based dendrimers: today and tomorrow. Molecules. 2025;30(21):4211. doi:10.3390/molecules30214211

Bindfit v0.5. Available online: http://supramolecular.org/bindfit. Accessed on 25 November 2025.

Brynn hibbert D, Thordarson P. The death of the Job plot, transparency, open science and online tools, uncertainty estimation methods and other developments in supramolecular chemistry data analysis. Chem Commun. 2016;52(87):12792–12805. doi:10.1039/C6CC03888C

Azwar S, Seow HF, Abdullah M, Faisal jabar M, Mohtarrudin N. Recent updates on mechanisms of resistance to 5-fluorouracil and reversal strategies in colon cancer treatment. Biol. 2021;10(9):854. doi:10.3390/biology10090854

Hu J, Li A, Guo Y, Ma T, Feng S. The relationship between tumor metabolism and 5-fluorouracil resistance. Biochem Pharmacol. 2023;218:115902. doi:10.1016/j.bcp.2023.115902

Kellum JA. Determinants of blood pH in health and disease. Crit Care. 2000;4(1):6. doi:10.1186/cc644

Yadav S, Sharma AK, Kumar P. Nanoscale self-assembly for therapeutic delivery. Front Bioeng Biotechnol. 2020;8:127. doi:10.3389/fbioe.2020.00127

Mekuria SL, Ouyang Z, Song C, Rodrigues J, Shen M, Shi X. Dendrimer-Based nanogels for cancer nanomedicine applications. Bioconjugate Chem. 2021;33(1):87–96. doi:10.1021/acs.bioconjchem.1c00587

Nsairat H, Lafi Z, Al-Najjar B, Al-Samydai A, Saqallah F, El-Tanani M, Oriquat G, Sa’Bi B, Ibrahim AA, Dellinger A, Alshaer W. How advanced are self-assembled nanomaterials for targeted drug delivery? A Comprehensive review of the literature. Int J Nanomed. 2025;20:2133–61. doi:10.2147/IJN.S490444

Negarandeh R, Saeedi M, Morteza-Semnani K, Akbari J, Ebrahimnejad P, Nokhodchi A. Synthesis and characterization of mesoporous silicate as core and low generation polyamidoamine dendrimer as shell for delivery of 5-fluorouracil from their nano complex. J Drug Deliv Sci Technol. 2024;101:106154. doi:10.1016/j.jddst.2024.106154

Radenković N, Nikodijević D, Jovankić J, Blagojević S, Milutinović M. Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cells. Eur J Pharmacol. 2024;983:176979. doi:10.1016/j.ejphar.2024.176979

Wang L, Wang X, Wang T, Zhuang Y, Wang G. Multi-omics analysis defines 5-fluorouracil drug resistance in 3D HeLa carcinoma cell model. Bioresour Bioprocess. 2021;8(1):135. doi:10.1186/s40643-021-00486-z




DOI: https://doi.org/10.15826/chimtech.9369

Copyright (c) 2025 Pavel Padnya, Ilona Svintsova, Igor Shiabiev, Dmitry Pysin, Olga Mostovaya, Bahdan Ranishenka, Alesia Stanavaya, Viktar Abashkin, Dzmitry Shcharbin, Anastasia Nazarova, Ivan Stoikov

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Scopus logo WorldCat logo DOAJ logo CAS logo BASE logo eLibrary logo

Chimica Techno Acta, 2014–2025
eISSN 2411-1414
Copyright Notice